Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
accurately, addressed, autoimmune, back, brought, calendar, Concurrently, diminish, director, disease, excise, expanded, expertise, failure, fastest, focused, frame, immunology, indemnification, nominal, objective, oncology, order, PA, pharmacology, Pittsburgh, QSP, recovered, Republic, reverse, role, scheduled, SLPI, successfully, suffer, surviving, therapeutic, Thursday, triangular
Removed:
produce, Wednesday
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view